Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on

G J Locker1, T Staudinger, S Knapp

  • 1Department of Internal Medicine I, University of Vienna, Vienna, Austria.

The Journal of Trauma
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Producer satisfaction, efficiency, and investment cost factors of different milking systems.

Journal of dairy science·2001
Same author

[Osteogenesis imperfecta. The effect of intramedullary nails in long tubular bones].

Ugeskrift for laeger·2001
Same author

[Endoscopic closure of cranionasal cerebrospinal fluid fistulas with the use of neuronavigation--"Computer Aided Surgery"].

Ugeskrift for laeger·2001
Same author

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

European journal of human genetics : EJHG·2001
Same author

Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2001
Same author

Principles of computer-assisted arthroscopy of the temporomandibular joint with optoelectronic tracking technology.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics·2001
Same journal

Article.

The Journal of trauma·2014
Same journal

Article.

The Journal of trauma·2014
Same journal

Program schedule for the sixty-fifth annual meeting of the american association for the surgery of trauma.

The Journal of trauma·2014
Same journal

Letters to the editor.

The Journal of trauma·2014
Same journal

Posttraumatic brachial plexitis.

The Journal of trauma·2011
Same journal

Incidental findings in focused assessment with sonography for trauma in hemodynamically stable blunt trauma patients: speaking about cost to benefit.

The Journal of trauma·2011
See all related articles

Prostaglandin E1 (PGE1) effectively prevented a drop in platelet count following massive blood transfusions in major surgery patients. This intervention also stabilized red blood cell counts and reduced intensive care unit stays.

Area of Science:

  • Anesthesiology and Critical Care Medicine
  • Hematology and Transfusion Medicine
  • Surgical Oncology

Background:

  • Massive blood transfusions during major surgery often lead to a decrease in platelet count.
  • Prophylactic administration of prostaglandin E1 (PGE1) was investigated as a potential countermeasure.

Purpose of the Study:

  • To assess the efficacy of prophylactic prostaglandin E1 (PGE1) in preventing post-transfusion thrombocytopenia.
  • To evaluate the impact of PGE1 on coagulation parameters and transfusion requirements.

Main Methods:

  • A prospective, randomized, double-blind, placebo-controlled study involving 45 patients undergoing major orthopedic surgery with massive transfusions (>10 units).
  • Patients received either intravenous PGE1 or a placebo for 72 hours post-surgery.

Related Experiment Videos

  • Platelet counts, red blood cell counts, hemoglobin, and coagulation markers were monitored.

    • Main Results:

    • PGE1 administration prevented a drop in platelet count, eliminating the need for platelet transfusions.
    • The PGE1 group showed more stable red blood cell counts and hemoglobin levels, requiring fewer red blood cell transfusions.
    • A trend towards reduced consumptive coagulopathy and a shorter intensive care unit stay was observed in the PGE1 group.

    Conclusions:

    • Prostaglandin E1 (PGE1) effectively prevents post-transfusion thrombocytopenia in patients undergoing massive transfusions.
    • PGE1 may mitigate transfusion-associated coagulation disturbances and improve patient outcomes.
    • PGE1 is recommended for consideration in patients requiring massive transfusions during major surgical procedures.